Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103130205 | 10313020 | 5 | F | 2010 | 20160630 | 20140718 | 20160706 | PER | US-PFIZER INC-2014200594 | PFIZER | 51.00 | YR | F | Y | 0.00000 | 20160706 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103130205 | 10313020 | 1 | PS | LYRICA | PREGABALIN | 1 | 100 MG, 3X/DAY | M56716 | 21446 | 100 | MG | TID | |||||||
| 103130205 | 10313020 | 2 | SS | LYRICA | PREGABALIN | 1 | 21446 | ||||||||||||
| 103130205 | 10313020 | 3 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | 7.5 MG, 2X/DAY | 0 | 7.5 | MG | BID | ||||||||
| 103130205 | 10313020 | 4 | C | LINZESS | LINACLOTIDE | 1 | 145 MG, 1X/DAY | 0 | 145 | MG | QD | ||||||||
| 103130205 | 10313020 | 5 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | QD | ||||||||
| 103130205 | 10313020 | 6 | C | GLYB/Metform | 2 | (METFORMIN HYDROCHLORIDE-500MG; GLIBENCLAMIDE-5 MG), 1X/DAY | 0 | QD | |||||||||||
| 103130205 | 10313020 | 7 | C | WELLBUTRIN XL | BUPROPION HYDROCHLORIDE | 1 | 150 MG, 3X/DAY | 0 | 150 | MG | TID | ||||||||
| 103130205 | 10313020 | 8 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | 5 MG, 2X/DAY | 0 | 5 | MG | BID | ||||||||
| 103130205 | 10313020 | 9 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | QD | ||||||||
| 103130205 | 10313020 | 10 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | 100 MG, 2X/DAY | 0 | 100 | MG | BID | ||||||||
| 103130205 | 10313020 | 11 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | 20 MG, 1X/DAY | 0 | 20 | MG | QD | ||||||||
| 103130205 | 10313020 | 12 | C | MOTRIN | IBUPROFEN | 1 | 800 MG, 2X/DAY | 0 | 800 | MG | BID | ||||||||
| 103130205 | 10313020 | 13 | C | NORVASC | AMLODIPINE BESYLATE | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103130205 | 10313020 | 1 | Diabetes mellitus |
| 103130205 | 10313020 | 2 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103130205 | 10313020 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103130205 | 10313020 | Pain | |
| 103130205 | 10313020 | Pain in extremity | |
| 103130205 | 10313020 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103130205 | 10313020 | 1 | 2010 | 0 |